AbCellera Biologics Inc. ABCL Pre-Tax Income (Foreign)
Pre-Tax Income (Foreign) at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s pre-tax income (foreign).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s pre-tax income (foreign)?
- AbCellera Biologics Inc. (ABCL) reported pre-tax income (foreign) of $2.72M in Q4 2025.
- How has AbCellera Biologics Inc.'s pre-tax income (foreign) changed year-over-year?
- AbCellera Biologics Inc.'s pre-tax income (foreign) increased by 199.5% year-over-year, from -$2.73M to $2.72M.
- What is the long-term trend for AbCellera Biologics Inc.'s pre-tax income (foreign)?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s pre-tax income (foreign) has grown at a -37.4% compound annual growth rate (CAGR), from -$27.71M to $10.87M.
- What does pre-tax income (foreign) mean?
- The pre-tax earnings generated from the company's international business operations. This metric highlights the profitability contribution of foreign markets and global expansion efforts.